Clinical Trials Browser

Not yet recruiting × Prostatic Neoplasms × apalutamide × Clear all

NCT06430411 2024-05-28

OLIGOMET

Not yet recruiting

Prostatic Neoplasms

NCT05717582 2023-02-08

CHAMPION

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms